ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Harkin to Ask NCI For Accounting Of Antineoplaston Trials

July 2, 1993

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000

Review Of Organ Site Program Requested By NCAB Set For Nov. 23-25; Eight Member Committee Named

August 21, 1981

Increased Lung Cancer Risk After Hodgkin’s Treatment

February 22, 2002

FDA Approves NDA for Sodium Fluoride F18

February 4, 2011

Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam

August 31, 2012